![](/img/cover-not-exists.png)
PMU55 - CONSEQUENCES ON ECONOMIC OUTCOMES OF GENERIC VERSUS BRAND-NAME DRUGS USED IN ROUTINE CLINICAL PRACTICE: THE CASE OF TREATING PERIPHERAL NEUROPATHIC PAIN OR GENERALIZED ANXIETY DISORDER WITH PREGABALIN
Sicras-Mainar, A., Rejas, J, Perez-Paramo, M., Sánchez-Alvarez, L., Navarro-Artieda, R., Darba, JVolume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.1891
Date:
October, 2018
File:
PDF, 377 KB
english, 2018